Amerise Biosciences Ltd. (AMERISE.BO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-89.4%

₹0.09

vs ₹0.83 price

Levered DCF

₹0.09

After debt service

Piotroski score

2 / 9

Weak

Altman Z-score

1.88

Grey zone

Rating

C+

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	245.83×	1,044.44×	-29.86×	-33.33×	7.22×	-11.76×	-26.55×	1,000×
P/B	0.73×	1.15×	0.81×	0.73×	0.7×	0.78×	0.73×	0.71×
P/S	0×	0×	0×	0×	0.44×	0×	0×	3.36×
EV / EBITDA	163.4×	814.25×	-29.7×	-33.98×	7.34×	-11.7×	-26.42×	959.57×
Gross margin	0.0%	0.0%	0.0%	0.0%	0.4%	0.0%	0.0%	0.8%
Operating margin	0.0%	0.0%	0.0%	0.0%	-0.2%	0.0%	0.0%	0.3%
Net margin	0.0%	0.0%	0.0%	0.0%	6.1%	0.0%	0.0%	0.3%
Current ratio	0.3×	0.01×	1.48×	0.37×	0.99×	0.04×	0.04×	180.09×
Debt / equity	0×	0×	0×	0.02×	0.01×	0×	0×	0×
Interest coverage	68.67×	0×	0×	0×	0×	0×	0×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	0.3%	0.1%	-2.7%	-2.2%	9.7%	-6.6%	-2.7%	0.1%
Return on invested capital	0.3%	-2.5%	-3.4%	-2.3%	-0.3%	-2.1%	-2.8%	0.1%
Return on assets	0.2%	0.1%	-2.7%	-2.1%	4.6%	-6.0%	-2.5%	0.1%
Free cash flow yield	0.0%	0.0%	-3.9%	-3.3%	1.5%	-10.0%	123.4%	-44.9%
Earnings yield	0.4%	0.1%	-3.4%	-3.0%	13.9%	-8.5%	-3.8%	0.1%
Enterprise value	₹33.7M	₹61.9M	₹43.4M	₹40.4M	₹40.3M	₹39.4M	₹39.4M	₹39.5M
Net debt / EBITDA	-28.73×	-2.92×	0.14×	-0.64×	0.13×	0.06×	0.17×	-4.48×
Cash conversion cycle (days)	0	0	0	0	-3	-4,101	-4,677	1,383